Preclinical and clinical activity of DZD1516, a full blood-brain barrier-penetrant, highly selective HER2 inhibitor. Zhang J, McAndrew NP, Wang X, Du Y, et al. Breast Cancer Res 2023;25:81.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang J, McAndrew NP, Wang X, Du Y, et al. Preclinical and clinical activity of DZD1516, a full blood-brain barrier-penetrant, highly selective HER2 inhibitor. Breast Cancer Res 2023;25:81.
PMID: 37415239